第一作者机构：[1]First Peoples Hosp Yunnan Prov, Dept Thorac Surg, Kunming, Yunnan, Peoples R China[2]3D Med Inc, Shanghai, Peoples R China
推荐引用方式(GB/T 7714)：
Peng Hao,Zhang Hushan,Zhang Libin,et al.Exploring the applicability of immunotherapy in different EGFR mutation subgroups based on data analysis of 9,659 Chinese patients with NSCLC.[J].JOURNAL OF CLINICAL ONCOLOGY.2021,39(15):doi:10.1200/JCO.2021.39.15_suppl.e21020.
APA：
Peng, Hao,Zhang, Hushan,Zhang, Libin,Wang, Yang,Shen, Xudong...&Wang, Han.(2021).Exploring the applicability of immunotherapy in different EGFR mutation subgroups based on data analysis of 9,659 Chinese patients with NSCLC..JOURNAL OF CLINICAL ONCOLOGY,39,(15)
MLA：
Peng, Hao,et al."Exploring the applicability of immunotherapy in different EGFR mutation subgroups based on data analysis of 9,659 Chinese patients with NSCLC.".JOURNAL OF CLINICAL ONCOLOGY 39..15(2021)
医学